R.E. Bouwstra
PhD student
Telephone:
E-mail:
r.e.bouwstra umcg.nl
Research
Publications
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Bouwstra, R., He, Y., de Boer, J. W., Kooistra, H., Cendrowicz, E., Fehrmann, R. S. N., Ammatuna, E., Eulenburg, C., Nijland, M., Huls, G., Bremer, E. & van Meerten, T., Oct-2019, In : Cancer immunology research. 7, 10, p. 1663-1671 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?
Bouwstra, R., van Meerten, T. & Bremer, E., 1-Jan-2019, In : Molecular and Cellular Oncology. 6, 3, 3 p., 1600349.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)
Van Meerten, T., Bouwstra, R., He, Y., Janneke, D. B., Kooistra, H., Fehrmann, R., Ammatuna, E., Huls, G. & Bremer, E., 29-Nov-2018, In : Blood. 132, Suppl.1, 3 p.Research output: Contribution to journal › Meeting Abstract › Academic
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
He, Y., Bouwstra, R., Wiersma, V. R., de Jong, M., Lourens, H. J., Fehrmann, R., de Bruyn, M., Ammatuna, E., Huls, G., van Meerten, T. & Bremer, E., 1-Feb-2019, In : Nature Communications. 10, 1, 8 p., 533.Research output: Contribution to journal › Article › Academic › peer-review
ID: 42067903